metoclopramide has been researched along with Esophageal Reflux in 203 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the prophylactic effectiveness of preoperative administration of maropitant citrate and metoclopramide hydrochloride in preventing postoperative clinical gastroesophageal reflux (GER) in dogs and to identify risk factors for clinical postoperative GER in dogs." | 9.30 | Evaluation of the effectiveness of preoperative administration of maropitant citrate and metoclopramide hydrochloride in preventing postoperative clinical gastroesophageal reflux in dogs. ( Fransson, BA; Jones, CT, 2019) |
| "The efficacy and tolerability of Cisapride effervescent granules for treatment of gastroesophageal reflux disease were compared to a metoclopramide-dimeticone combination." | 9.07 | [A new granular effervescent 10-mg formulation of cisapride in the treatment of gastroesophageal reflux]. ( Di Felice, F; Grossi, L; Marzio, L, 1993) |
| "Twenty-four infants, 1 to 18 months-old, who were referred to four centers for suspected gastroesophageal reflux and whose esophageal pH after a standard formula meal given at 9 to 10 am (Ho-day 1) fulfilled the criterion of being < 4 for more than 5% of the time between H1 and H6, entered a double-blind placebo-controlled dose-response trial of metoclopramide (M)." | 9.07 | Dose-response study of metoclopramide in gastroesophageal reflux in infancy. ( Bellissant, E; Bouglé, D; d'Athis, P; Duhamel, JF; Gouyon, JB; Guillot, M; Moran, C; Pons, G; Rey, E; Richard, MO, 1993) |
| "Ranitidine and metoclopramide were compared for their ability to reduce esophageal acid contact time and heartburn." | 9.06 | Esophageal acid contact time and heartburn in acute treatment with ranitidine and metoclopramide. ( Finn, A; Orr, WC; Russell, J; Wilson, T, 1990) |
| "The effect of metoclopramide on gastroesophageal reflux was studied in 30 infants less than 1 year of age." | 9.06 | Randomized, prospective double-blind trial of metoclopramide and placebo for gastroesophageal reflux in infants. ( Calhoun, J; Kauffman, RE; Kuhns, L; Tolia, V, 1989) |
| "Since gastro-oesophageal reflux disease is due to disturbances of oesophageal motility, motor and pH measurements are an important means to test a new anti-reflux drug, cisapride." | 9.06 | Cisapride in gastro-oesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH. ( Li, Q; Wienbeck, M, 1989) |
| "In a double-blind, randomized study, the clinical effects of 5 mg and 10 mg of cisapride three times daily were compared with those of 10 mg of metoclopramide three times daily in 114 patients with symptoms of gastroesophageal reflux, mainly diurnal and nocturnal heartburn and regurgitation." | 9.06 | Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease. ( Arabehety, JT; Fassler, S; Leitão, OR; Olarte, M; Serrano, C, 1988) |
| "This study examined the effect of metoclopramide on lower esophageal sphincter (LES) pressure, and frequency and duration of reflux episodes in 28 children (mean age (+/- SD) 9 +/- 11 months) referred for evaluation of gastroesophageal reflux (GER)." | 9.06 | Metoclopramide in gastroesophageal reflux of infancy. ( Forbes, DA; Gall, DG; Machida, HM; Scott, RB, 1988) |
| "Ten patients with gastroesophageal reflux disease participated in a randomized, double-blind, crossover study in which they received a single 20-mg oral dose of metoclopramide or a placebo 15 minutes before a provocative test meal." | 9.05 | Prevention of meal-induced heartburn and regurgitation with metoclopramide in patients with gastroesophageal reflux. ( Bartolomeo, RS; Fuchs, B, 1982) |
| "Postcibal provoked gastrooesophageal reflux of 14 patients with symptoms of reflux was reduced significantly by metoclopramide (Cerucal, 10 mg i." | 9.05 | [Effect of metoclopramide (Cerucal) on postprandial gastroesophageal reflux]. ( Pflücke, F, 1981) |
| "A double-blind comparison of metoclopramide versus placebo was performed on 8 cirrhotic patients with nausea (8 cases) and heartburn (3 of the 8 cases) plus mild portal-systemic encephalopathy." | 9.05 | Successful administration of metoclopramide for the treatment of nausea in patients with advanced liver disease. A double-blind controlled trial. ( Ballesteros, A; Briones, A; Garcia Ramos, G; Garza, J; Rosales, J; Strauss, R; Uribe, M; Villalobos, A, 1985) |
| "Since metoclopramide increases lower-esophageal-sphincter pressure in patients with gastroesophageal reflux, we compared the effects of metoclopramide, 10 mg four times daily, with those of placebo on symptoms in 31 patients with chronic heartburn." | 9.04 | A controlled trial of metoclopramide in symptomatic gastroesophageal reflux. ( Cooney, C; Ippoliti, AF; McCallum, RW; Sturdevant, RA, 1977) |
| "Forty-seven infants and children suffering from chronic vomiting or regurgitation, participated in a two-week double-blind trial comparing 1% drops of domperidone, 1% metoclopramide drops or placebo." | 9.04 | Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide. ( Ameryckx, L; De Loore, I; Van Ravensteyn, H, 1979) |
| "The effect of oral metoclopramide (15 mg), AlMgOH (30 ml), and placebo on the cumulative duration of gastroesophageal reflux induced by a protein-rich meal was compared in 15 patients with reflux esophagitis." | 9.04 | Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state. ( Behar, J; Biancani, P, 1976) |
| "Metoclopramide is a commonly used drug to treat gastroesophageal reflux disease in infants." | 8.83 | Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review. ( Hibbs, AM; Lorch, SA, 2006) |
| "This research aimed to evaluate the effect of metoclopramide and ranitidine in the prevention of gastroesophageal reflux episodes during anesthetic procedures." | 7.78 | Evaluation of metoclopramide and ranitidine on the prevention of gastroesophageal reflux episodes in anesthetized dogs. ( Bonfá, LP; Costa, PR; Favarato, ES; Favarato, LS; Monteiro, BS; Nehme, RC; Souza, MV, 2012) |
| " We diagnosed an esophageal hamartoma in an infant girl who had first presented when she was 8 days old with symptoms of apnea and cyanosis." | 7.76 | Esophageal hamartoma as an unusual cause of neonatal apnea and bradycardia. ( Coury, J; Steinfeld, J; Zwillenberg, D; Zwillenberg, S, 2010) |
| "To determine the effect of 2 doses of metoclopramide on the incidence of gastroesophageal reflux (GER) in anesthetized dogs." | 7.73 | Influence of metoclopramide on gastroesophageal reflux in anesthetized dogs. ( Evans, AT; Mauer, WA; Wilson, DV, 2006) |
| "We reviewed the medical records of all infants metoclopramide in association with apnea." | 7.71 | Gastroesophageal reflux medications in the treatment of apnea in premature infants. ( Carlton, DP; Kimball, AL, 2001) |
| "Gynecomastia and galactorrhea stemming from hyperprolactinemia have been reported in adults after the use of metoclopramide." | 7.69 | Gynecomastia with metoclopramide use in pediatric patients. ( Madani, S; Tolia, V, 1997) |
| "The long-term safety of metoclopramide was evaluated for up to 30 months in 269 patients with chronic symptoms of gastroesophageal reflux disease." | 7.67 | Evaluation of the safety of metoclopramide in patients with gastroesophageal reflux disease. ( Taylor, DM, 1984) |
| "The effects of intravenous metoclopramide (Maxolon) on the lower oesophageal sphincter (LOS) were studied in three groups of patients, one group being normal control and the other two being pregnant females, one without heartburn and the other with." | 7.66 | The effect of metoclopramide on the lower oesophageal sphincter in late pregnancy. ( Brock-Utne, JG; Dimopoulos, GE; Dow, TG; Moshal, MG; Welman, S, 1978) |
| "Metoclopramide was introduced routinely in premature babies followed in ambulatory care by the Colombian Kangaroo Mother Care program (KMCP), based on a 2004 Cochrane review." | 7.01 | Randomized Clinical Trial of Metoclopramide as Prophylaxis of Gastroesophageal Reflux Disease in Preterm Infants. ( Charpak, N; Montealegre-Pomar, ADP, 2021) |
| "Bethanechol did not increase gastric emptying." | 6.65 | Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. ( Berkowitz, DM; Fink, SM; Lerner, E; McCallum, RW, 1983) |
| "Pharmacotherapy for gastroesophageal reflux (GER) in neonates, aimed at interfering with this physiologic process and potentially reducing the negative sequelae that providers often attribute to GER, consists primarily of drugs that increase the viscosity of feeds, reduce stomach acidity, or improve gut motility." | 6.48 | Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates. ( Cotten, CM; Malcolm, WF, 2012) |
| "Gastro-esophageal reflux (GER) is the refluxing of gastric contents into the esophagus." | 6.46 | WITHDRAWN: Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years. ( Craig, WR; Hanlon-Dearman, A; Moffatt, M; Sinclair, C; Taback, SP, 2010) |
| "Gastro-esophageal reflux (GER) is the refluxing of gastric contents into the esophagus." | 6.42 | Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years. ( Craig, WR; Hanlon-Dearman, A; Moffatt, M; Sinclair, C; Taback, S, 2004) |
| "To investigate the prophylactic effectiveness of preoperative administration of maropitant citrate and metoclopramide hydrochloride in preventing postoperative clinical gastroesophageal reflux (GER) in dogs and to identify risk factors for clinical postoperative GER in dogs." | 5.30 | Evaluation of the effectiveness of preoperative administration of maropitant citrate and metoclopramide hydrochloride in preventing postoperative clinical gastroesophageal reflux in dogs. ( Fransson, BA; Jones, CT, 2019) |
| "Oral tablet formulations of metoclopramide are effective therapies for gastroparesis and gastro-oesophageal reflux disease; however, difficulty swallowing tablets or nausea/vomiting may reduce patient adherence to therapy." | 5.14 | Pharmacokinetic comparison of orally-disintegrating metoclopramide with conventional metoclopramide tablet formulation in healthy volunteers. ( Fass, R; Pieniaszek, HJ; Thompson, JR, 2009) |
| "To evaluate the asthma outcome of treatment with ranitidine or esomeprazole plus metoclopramide in older children with moderate-persistent asthma and gastroesophageal reflux disease (GERD)." | 5.12 | Effect of antireflux treatment on asthma exacerbations in nonatopic children. ( Haydel, R; Khoshoo, V, 2007) |
| "The efficacy and tolerability of Cisapride effervescent granules for treatment of gastroesophageal reflux disease were compared to a metoclopramide-dimeticone combination." | 5.07 | [A new granular effervescent 10-mg formulation of cisapride in the treatment of gastroesophageal reflux]. ( Di Felice, F; Grossi, L; Marzio, L, 1993) |
| "Ranitidine and metoclopramide were compared for their ability to reduce esophageal acid contact time and heartburn." | 5.06 | Esophageal acid contact time and heartburn in acute treatment with ranitidine and metoclopramide. ( Finn, A; Orr, WC; Russell, J; Wilson, T, 1990) |
| "The effect of metoclopramide on gastroesophageal reflux was studied in 30 infants less than 1 year of age." | 5.06 | Randomized, prospective double-blind trial of metoclopramide and placebo for gastroesophageal reflux in infants. ( Calhoun, J; Kauffman, RE; Kuhns, L; Tolia, V, 1989) |
| "Since gastro-oesophageal reflux disease is due to disturbances of oesophageal motility, motor and pH measurements are an important means to test a new anti-reflux drug, cisapride." | 5.06 | Cisapride in gastro-oesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH. ( Li, Q; Wienbeck, M, 1989) |
| "In a double-blind, randomized study, the clinical effects of 5 mg and 10 mg of cisapride three times daily were compared with those of 10 mg of metoclopramide three times daily in 114 patients with symptoms of gastroesophageal reflux, mainly diurnal and nocturnal heartburn and regurgitation." | 5.06 | Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease. ( Arabehety, JT; Fassler, S; Leitão, OR; Olarte, M; Serrano, C, 1988) |
| "This study examined the effect of metoclopramide on lower esophageal sphincter (LES) pressure, and frequency and duration of reflux episodes in 28 children (mean age (+/- SD) 9 +/- 11 months) referred for evaluation of gastroesophageal reflux (GER)." | 5.06 | Metoclopramide in gastroesophageal reflux of infancy. ( Forbes, DA; Gall, DG; Machida, HM; Scott, RB, 1988) |
| "Ten patients with gastroesophageal reflux disease participated in a randomized, double-blind, crossover study in which they received a single 20-mg oral dose of metoclopramide or a placebo 15 minutes before a provocative test meal." | 5.05 | Prevention of meal-induced heartburn and regurgitation with metoclopramide in patients with gastroesophageal reflux. ( Bartolomeo, RS; Fuchs, B, 1982) |
| " Still one week after the end off the treatment with metoclopramide the gastrooesophageal reflux under fasting conditions was significantly decreased compared with the beginning of the treatment, whereas the reflux stimulated under pentagastrin did not show a remaining influence." | 5.05 | [Effect of metoclopramide on complaints of reflux disease]. ( Pflücke, F, 1981) |
| "Postcibal provoked gastrooesophageal reflux of 14 patients with symptoms of reflux was reduced significantly by metoclopramide (Cerucal, 10 mg i." | 5.05 | [Effect of metoclopramide (Cerucal) on postprandial gastroesophageal reflux]. ( Pflücke, F, 1981) |
| "A double-blind comparison of metoclopramide versus placebo was performed on 8 cirrhotic patients with nausea (8 cases) and heartburn (3 of the 8 cases) plus mild portal-systemic encephalopathy." | 5.05 | Successful administration of metoclopramide for the treatment of nausea in patients with advanced liver disease. A double-blind controlled trial. ( Ballesteros, A; Briones, A; Garcia Ramos, G; Garza, J; Rosales, J; Strauss, R; Uribe, M; Villalobos, A, 1985) |
| "Since metoclopramide increases lower-esophageal-sphincter pressure in patients with gastroesophageal reflux, we compared the effects of metoclopramide, 10 mg four times daily, with those of placebo on symptoms in 31 patients with chronic heartburn." | 5.04 | A controlled trial of metoclopramide in symptomatic gastroesophageal reflux. ( Cooney, C; Ippoliti, AF; McCallum, RW; Sturdevant, RA, 1977) |
| "Forty-seven infants and children suffering from chronic vomiting or regurgitation, participated in a two-week double-blind trial comparing 1% drops of domperidone, 1% metoclopramide drops or placebo." | 5.04 | Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide. ( Ameryckx, L; De Loore, I; Van Ravensteyn, H, 1979) |
| "The effect of oral metoclopramide (15 mg), AlMgOH (30 ml), and placebo on the cumulative duration of gastroesophageal reflux induced by a protein-rich meal was compared in 15 patients with reflux esophagitis." | 5.04 | Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state. ( Behar, J; Biancani, P, 1976) |
| "The effects of oral metoclopramide, 10 and 20 mg, bethanechol, 25 mg, and placebo on lower esophageal sphincter pressure (LESP) were studied in 15 men with symptoms of gastroesophageal reflux and basal LESP less than 11 mm Hg." | 5.04 | Comparative effects of metoclopramide and bethanechol on lower esophageal sphincter pressure in reflux patients. ( Curry, N; Kline, MM; McCallum, RW; Sturdevant, RA, 1975) |
| "Metoclopramide is a commonly used drug to treat gastroesophageal reflux disease in infants." | 4.83 | Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review. ( Hibbs, AM; Lorch, SA, 2006) |
| "English-language literature was accessed using MEDLINE (1970-June 2004) with metoclopramide, erythromycin, macrolides, gastroesophageal reflux, and gastrointestinal motility as the search terms." | 4.82 | Prokinetic drug therapy in children: a review of current options. ( Batres, LA; Chicella, MF; Dice, JE; Heesters, MS, 2005) |
| " These pharmacological differences have clinical relevance: metoclopramide and domperidon could not consistently prove efficacy in functional dyspepsia and GORD." | 4.79 | [Pharmacologic and clinical differentiation of prokinetic drugs]. ( Greving, I; May, B, 1996) |
| "The author discusses the role of prokinetic agents, such as bethanechol, metoclopramide, domperidone, and cisipride in the management of gastroesophageal reflux disease." | 4.78 | Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents. ( McCallum, RW, 1990) |
| "Domperidone and metoclopramide are prokinetics commonly prescribed off-label to infants and younger children in an attempt to treat gastro-oesophageal reflux symptoms." | 3.81 | Prokinetics prescribing in paediatrics: evidence on cisapride, domperidone, and metoclopramide. ( Ashby, D; Croft, NM; Mt-Isa, S; Sutcliffe, A; Tomlin, S; Underwood, M; Williamson, P, 2015) |
| "This research aimed to evaluate the effect of metoclopramide and ranitidine in the prevention of gastroesophageal reflux episodes during anesthetic procedures." | 3.78 | Evaluation of metoclopramide and ranitidine on the prevention of gastroesophageal reflux episodes in anesthetized dogs. ( Bonfá, LP; Costa, PR; Favarato, ES; Favarato, LS; Monteiro, BS; Nehme, RC; Souza, MV, 2012) |
| " We diagnosed an esophageal hamartoma in an infant girl who had first presented when she was 8 days old with symptoms of apnea and cyanosis." | 3.76 | Esophageal hamartoma as an unusual cause of neonatal apnea and bradycardia. ( Coury, J; Steinfeld, J; Zwillenberg, D; Zwillenberg, S, 2010) |
| " Although metoclopramide increased LES and barrier pressures, it did not attenuate cricoid pressure-induced relaxation of the LES and barrier pressures and thus seems to have no value in preventing gastroesophageal reflux during cricoid pressure." | 3.74 | Metoclopramide does not attenuate cricoid pressure-induced relaxation of the lower esophageal sphincter in awake volunteers. ( Bruninga, KW; Dodlapatii, J; Joseph, NJ; Salem, MR, 2008) |
| "We describe a 1-year-old girl who developed orofaciolingual stereotypy at age 2 months after a 17-day treatment with metoclopramide for gastroesophageal reflux." | 3.73 | Metoclopramide-induced tardive dyskinesia in an infant. ( Jankovic, J; Mejia, NI, 2005) |
| " Management of the infant with gastroesophageal reflux disease, in addition to nonpharmacological interventions pharmacologic therapy, including metoclopramide HCl and Fe (6 mg/kg per day, oral) was useful for the patients, and their paroxysmal attacks decreased dramatically (0-2 attacks/day)." | 3.73 | Sandifer Syndrome: a continuing problem of misdiagnosis. ( Kabakuş, N; Kurt, A, 2006) |
| "We reviewed the medical records of all infants metoclopramide in association with apnea." | 3.71 | Gastroesophageal reflux medications in the treatment of apnea in premature infants. ( Carlton, DP; Kimball, AL, 2001) |
| "Despite its wide use as a prokinetic agent in neonates and infants with gastroesophageal reflux (GER), the pharmacokinetics of metoclopramide have not been characterized in this pediatric subpopulation." | 3.70 | Pharmacokinetics of metoclopramide in neonates. ( Blumer, JL; Kearns, GL; Reed, MD; van den Anker, JN, 1998) |
| "Patient suffers central nervous system damage after prolonged use of metoclopramide and ranitidine hydrochloride to control gastroesophageal reflux." | 3.69 | Quality problems that result in adverse outcomes provide opportunities for quality improvement. ( , 1996) |
| "Gynecomastia and galactorrhea stemming from hyperprolactinemia have been reported in adults after the use of metoclopramide." | 3.69 | Gynecomastia with metoclopramide use in pediatric patients. ( Madani, S; Tolia, V, 1997) |
| "The long-term safety of metoclopramide was evaluated for up to 30 months in 269 patients with chronic symptoms of gastroesophageal reflux disease." | 3.67 | Evaluation of the safety of metoclopramide in patients with gastroesophageal reflux disease. ( Taylor, DM, 1984) |
| "The effect of metoclopramide premedication on the incidence of gastric regurgitation and postoperative nausea and vomiting was studied in 101 women during gynaecological procedures performed under mask anaesthesia." | 3.67 | Silent regurgitation in day case gynaecological patients. ( Anderson, WG; Miller, CD, 1988) |
| " There were 28 patients in group I whose major presenting sign was recurrent pneumonia due to GER, and 22 patients in group II, with apnea caused by GER." | 3.67 | Gastroesophageal reflux. pH probe-directed therapy. ( Curreri, PW; Powell, RW; Ramenofsky, ML, 1986) |
| "Pediatric patients with organic and congenital gastrointestinal disorders, including gastroesophageal reflux, may benefit from metoclopramide therapy." | 3.66 | Metoclopramide in the treatment of an infant with gastroesophageal hypomotility. ( Ponte, CD, 1982) |
| "The effects of intravenous metoclopramide (Maxolon) on the lower oesophageal sphincter (LOS) were studied in three groups of patients, one group being normal control and the other two being pregnant females, one without heartburn and the other with." | 3.66 | The effect of metoclopramide on the lower oesophageal sphincter in late pregnancy. ( Brock-Utne, JG; Dimopoulos, GE; Dow, TG; Moshal, MG; Welman, S, 1978) |
| "Metoclopramide was introduced routinely in premature babies followed in ambulatory care by the Colombian Kangaroo Mother Care program (KMCP), based on a 2004 Cochrane review." | 3.01 | Randomized Clinical Trial of Metoclopramide as Prophylaxis of Gastroesophageal Reflux Disease in Preterm Infants. ( Charpak, N; Montealegre-Pomar, ADP, 2021) |
| "Pharyngocutaneous fistula is a serious complication after laryngectomy." | 2.68 | Gastroesophageal reflux prophylaxis decreases the incidence of pharyngocutaneous fistula after total laryngectomy. ( Park, P; Seikaly, H, 1995) |
| "Conventional medical treatment for gastroesophageal reflux disease involves life-style modifications and combination drug therapy, but few studies have included these features in their protocols." | 2.67 | Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. ( Spechler, SJ, 1992) |
| "Medical treatment of gastroesophageal reflux disease often results in improvement of symptoms." | 2.66 | 24-hour esophageal pH monitoring before and after medical therapy for reflux esophagitis. ( Lieberman, DA, 1988) |
| "Gastroesophageal reflux disease (GERD) is one of the most common problems in gastrointestinal disorders." | 2.50 | [Current issues on gastroesophageal reflux disease]. ( Jeong, ID; Kim, BJ; Kim, JH; Kim, SE; Kim, SW; Kim, YS; Oh, TH; Park, MI; Sung, HY, 2014) |
| "Of note, co-existing gastroesophageal reflux disease (GERD), Helicobacter pylori infection, and psychosocial factors may have a negative impact on the management of NVP." | 2.50 | The outpatient management and special considerations of nausea and vomiting in pregnancy. ( Clark, SM; Dutta, E; Hankins, GD, 2014) |
| "Gastro-esophageal reflux (GER) is the refluxing of gastric contents into the esophagus." | 2.46 | WITHDRAWN: Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years. ( Craig, WR; Hanlon-Dearman, A; Moffatt, M; Sinclair, C; Taback, SP, 2010) |
| "Heartburn is a normal consequence of pregnancy." | 2.43 | Review article: the management of heartburn in pregnancy. ( Richter, JE, 2005) |
| "Gastro-oesophageal reflux (GOR) and gastro-oesophageal reflux disease (GORD) occur frequently during the first months of life." | 2.43 | The diagnosis and management of gastro-oesophageal reflux in infants. ( Hauser, B; Salvatore, S; Vandenplas, Y, 2005) |
| "Therapeutic modalities for gastroesophageal reflux disease (GERD) continue to evolve despite the introduction of proton pump inhibitors (PPIs), the most successful antireflux class of drugs." | 2.42 | Treatment of gastroesophageal reflux disease. ( Bautista, J; Fass, R; Janarthanan, S, 2003) |
| "Gastro-esophageal reflux (GER) is the refluxing of gastric contents into the esophagus." | 2.42 | Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years. ( Craig, WR; Hanlon-Dearman, A; Moffatt, M; Sinclair, C; Taback, S, 2004) |
| "Depending on the severity of the GERD manifestation, pharmacotherapy is often added." | 2.41 | Management of supraesophageal complications of gastroesophageal reflux disease in infants and children. ( Orenstein, SR, 2000) |
| "Gastroesophageal reflux disease (GERD) is one of the most common diagnoses in a gastroenterologist's practice." | 2.41 | Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease. ( Allescher, HD; Meining, A; Storr, M, 2001) |
| "The key factor in the pathogenesis of GERD is disordered function of the lower esophageal sphincter." | 2.40 | Prokinetic therapy in gastroesophageal reflux disease. ( Champion, MC, 1997) |
| "Dyspepsia affects one in four Australians; of those who present in general practice, the majority will have functional or non-ulcer dyspepsia, with no structural explanation for their symptoms." | 2.39 | Modern management of dyspepsia. ( Talley, NJ, 1996) |
| "The vast majority of patients with GERD have mild symptoms, no gross endoscopic evidence of esophagitis, and little risk of developing complications." | 2.39 | Influence of pathophysiology, severity, and cost on the medical management of gastroesophageal reflux disease. ( Reynolds, JC, 1996) |
| " The appropriate use of prokinetic agents in these groups requires an understanding of the unique dosage considerations that may be necessary to ensure safe, effective therapy." | 2.39 | Use of prokinetic agents in special populations. ( Horn, JR, 1996) |
| " The ideal therapy for GORD will have linear pharmacokinetics, a relatively long plasma half-life (t1/2), a duration of action allowing once daily administration, and a stable effect independent of interactions with food, antacids and other drugs." | 2.39 | Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. ( Berstad, A; Hatlebakk, JG, 1996) |
| "The esophageal pH probe identifies gastroesophageal reflux." | 2.38 | Chronic pulmonary aspiration in children. ( Bauer, ML; Figueroa-Colon, R; Georgeson, K; Young, DW, 1993) |
| "Metoclopramide is a useful adjunctive drug for intestinal intubation and radiologic examination." | 2.38 | Metoclopramide: a dopamine receptor antagonist. ( DiPalma, JR, 1990) |
| "Metoclopramide also has an important place in the investigation of the role of dopamine in physiological and pathological processes." | 2.37 | Metoclopramide--a review. ( Desmond, PV; Watson, KJ, 1986) |
| "PONV was experienced by 74." | 1.91 | Prevalence, Risk Factors, and Management of Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy (a Retrospective Multicentric Study). ( Abuyousif, YA; Aldossary, HM; Attia, M; El Hefnawy, E; El Nakeeb, A; Elmorshedi, M; Mohammed, MN; Rashad, AE; Salem, A; Zaid, A, 2023) |
| "Metoclopramide was associated with increased risk of AEs compared with erythromycin." | 1.42 | Use and Safety of Erythromycin and Metoclopramide in Hospitalized Infants. ( Arnold, C; Benjamin, DK; Cheeseman, J; Cho, J; Chu, V; Clark, RH; Ericson, JE; Hornik, CP; Kaneko, S; Smith, PB; Wilson, E, 2015) |
| "Metoclopramide is a prokinetic drug used to treat GERD and it has been reported to be a most commonly prescribed medication in neonatal intensive care unit (NICU)." | 1.39 | Is metoclopramide safe for the premature infant? ( Dilmen, U; Eras, Z; Oğuz, SS, 2013) |
| "Group 1 comprised 47 patients with GERD and group 2 49 patients with gastric and duodenal UD." | 1.35 | [Combined therapy of acid-dependent gastrointestinal disorders with the use of antacidic drug Relcer]. ( Andreev, NG; Beliantseva, EV; Golubev, NN; Maev, IV; Odintsova, AN; Samsonov, AA, 2009) |
| "The cough was eliminated or markedly improved in 38 patients (86%) after 4 weeks and by 8 weeks in the remaining 6 patients." | 1.32 | Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. ( Kallay, MC; Poe, RH, 2003) |
| "Pharyngocutaneous fistula is a serious complication of total laryngectomy." | 1.31 | [Pharmacological prophylaxis of gastroesophageal reflux. Incidence of pharyngocutaneous fistula after total laryngectomy]. ( Mas Mercant, S; Romaguera Lliso, A; Sarría Echegaray, P; Soler Vilarrasa, R; Tomás Barberán, M, 2000) |
| "All 8 patients had initial control of laryngospasm." | 1.31 | Laryngospasm: an atypical manifestation of severe gastroesophageal reflux disease (GERD). ( Maceri, DR; Zim, S, 2001) |
| " The patient demonstrated toxic extrapyramidal effects." | 1.30 | Metoclopramide toxicity in an infant. ( Batts, KF; Munter, DW, 1998) |
| "The relationship between gastroesophageal reflux disease and these symptoms has been studied but remains unclear." | 1.29 | Role of gastroesophageal reflux disease in patients with cervical symptoms. ( Freeman, J; Goldberg, M; Mendelsohn, M; Rival, R; Rosgen, S; Wong, R, 1995) |
| "Indications for the studies were upper airway obstruction (UAO) and congenital choanal atresia (CCA)." | 1.29 | Proximal pH-metry for diagnosis of upper airway complications of gastroesophageal reflux. ( Beste, DJ; Conley, SF; Werlin, SL, 1995) |
| "The child presented with intermittent stridor which responded promptly to treatment of her reflux." | 1.29 | Paradoxical vocal cord dysfunction in an infant with stridor and gastroesophageal reflux. ( Heatley, DG; Swift, E, 1996) |
| "Gastro-oesophageal reflux disease is a very common disorder." | 1.29 | [Internal medicine therapy in reflux disease]. ( Flad, J, 1996) |
| "The authors describe two cases of tardive akathisia following metoclopramide therapy, in which there were concomitant symptoms of agitated depression." | 1.27 | Tardive akathisia and agitated depression during metoclopramide therapy. ( Bownes, IT; Curran, P; Shearer, RM, 1984) |
| "Metoclopramide is a promising drug used not infrequently by practicing physicians." | 1.27 | Respiratory failure due to metoclopramide. ( Quinn, SF, 1983) |
| "Recent data describe the acid aspiration syndrome (AAS) as the cause of 25% of maternal deaths associated with anaesthesia and 19% of all deaths totally attributable to anaesthesia (DHSS, 1982; Lunn and Mushin, 1982)." | 1.27 | Aspiration of gastric contents. ( Nimmo, WS, 1985) |
| "Gastroesophageal reflux (GER) during infancy is a disorder of unknown etiology which may be associated with abnormalities of upper gastrointestinal motor function." | 1.27 | Effect of bethanechol and metoclopramide on upper gastrointestinal motility in the kitten. ( Gryboski, J; Hillemeier, C; McCallum, R; Oertel, R, 1986) |
| "Gastroesophageal reflux (GER) disease is a common, multifactorial medical condition that may be difficult to treat." | 1.27 | A critical review of current medical therapy for gastroesophageal reflux disease. ( Richter, JE, 1986) |
| "Gastro-esophageal reflux is discussed with reference to pathogenetic factors and therapy." | 1.26 | [Therapy of gastro-esophageal reflux disease]. ( Güller, R, 1980) |
| "Gallstone dyspepsia is essentially a functional disease--a disorder of gastroduodenal motility." | 1.25 | Cholecystectomy and gallstone dyspepsia. Clinical and physiological study of a symptom complex. ( Johnson, AG, 1975) |
| "A sliding hiatus hernia is a common radiological finding and is not always relevant to the patient's symptoms." | 1.25 | Common gastroenterological problems. II.--Sliding hiatus hernia. ( Salter, RH, 1975) |
| "Initially the treatment of gastroesophageal reflux is one of prevention." | 1.25 | Recent advances in management of gastroesophageal reflux. ( Cohen, S, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 100 (49.26) | 18.7374 |
| 1990's | 55 (27.09) | 18.2507 |
| 2000's | 30 (14.78) | 29.6817 |
| 2010's | 15 (7.39) | 24.3611 |
| 2020's | 3 (1.48) | 2.80 |
| Authors | Studies |
|---|---|
| Montealegre-Pomar, ADP | 1 |
| Charpak, N | 1 |
| Rashad, AE | 1 |
| El Hefnawy, E | 1 |
| Elmorshedi, M | 1 |
| Abuyousif, YA | 1 |
| Salem, A | 1 |
| Attia, M | 1 |
| El Nakeeb, A | 1 |
| Zaid, A | 1 |
| Aldossary, HM | 1 |
| Mohammed, MN | 1 |
| Kim, M | 1 |
| Ye, D | 1 |
| John Kim, CS | 1 |
| Zhou, W | 1 |
| Tester, DJ | 1 |
| Giudicessi, JR | 1 |
| Ackerman, MJ | 1 |
| Jones, CT | 1 |
| Fransson, BA | 1 |
| Eras, Z | 1 |
| Oğuz, SS | 1 |
| Dilmen, U | 1 |
| Donatelli, NS | 1 |
| Somes, J | 1 |
| Uña, E | 1 |
| Alonso, P | 1 |
| Heiberger, A | 1 |
| Kim, JH | 1 |
| Kim, BJ | 1 |
| Kim, SW | 1 |
| Kim, SE | 1 |
| Kim, YS | 1 |
| Sung, HY | 1 |
| Oh, TH | 1 |
| Jeong, ID | 1 |
| Park, MI | 1 |
| Clark, SM | 1 |
| Dutta, E | 1 |
| Hankins, GD | 1 |
| Ericson, JE | 1 |
| Arnold, C | 1 |
| Cheeseman, J | 1 |
| Cho, J | 1 |
| Kaneko, S | 1 |
| Wilson, E | 1 |
| Clark, RH | 2 |
| Benjamin, DK | 1 |
| Chu, V | 1 |
| Smith, PB | 1 |
| Hornik, CP | 1 |
| Mt-Isa, S | 1 |
| Tomlin, S | 1 |
| Sutcliffe, A | 1 |
| Underwood, M | 1 |
| Williamson, P | 1 |
| Croft, NM | 1 |
| Ashby, D | 1 |
| Weinstein, RB | 1 |
| Fife, D | 1 |
| Sloan, S | 1 |
| Voss, EA | 1 |
| Treem, W | 1 |
| Salem, MR | 1 |
| Bruninga, KW | 1 |
| Dodlapatii, J | 1 |
| Joseph, NJ | 1 |
| Paturi, B | 1 |
| Ryan, RM | 1 |
| Michienzi, KA | 1 |
| Lakshminrusimha, S | 1 |
| Kumar, Y | 1 |
| Sarvananthan, R | 1 |
| Fass, R | 2 |
| Pieniaszek, HJ | 1 |
| Thompson, JR | 1 |
| Wheatley, E | 1 |
| Kennedy, KA | 1 |
| Barney, CK | 1 |
| Baer, VL | 1 |
| Scoffield, SH | 1 |
| Lambert, DK | 1 |
| Cook, M | 1 |
| Christensen, RD | 1 |
| Spitzer, AR | 1 |
| Maev, IV | 1 |
| Samsonov, AA | 1 |
| Beliantseva, EV | 1 |
| Golubev, NN | 1 |
| Odintsova, AN | 1 |
| Andreev, NG | 1 |
| Coury, J | 1 |
| Steinfeld, J | 1 |
| Zwillenberg, D | 1 |
| Zwillenberg, S | 1 |
| Craig, WR | 2 |
| Hanlon-Dearman, A | 2 |
| Sinclair, C | 2 |
| Taback, SP | 1 |
| Moffatt, M | 2 |
| Gottrand, F | 2 |
| Favarato, ES | 1 |
| Souza, MV | 1 |
| Costa, PR | 1 |
| Favarato, LS | 1 |
| Nehme, RC | 1 |
| Monteiro, BS | 1 |
| Bonfá, LP | 1 |
| Malcolm, WF | 2 |
| Cotten, CM | 2 |
| Poe, RH | 1 |
| Kallay, MC | 1 |
| Bautista, J | 1 |
| Janarthanan, S | 1 |
| Mejia, NI | 1 |
| Jankovic, J | 1 |
| Agarwal, S | 1 |
| Trucco, S | 1 |
| Longhurst, C | 1 |
| Sectish, TC | 1 |
| Karadsheh, M | 1 |
| Defendi, GL | 1 |
| Taback, S | 1 |
| Chicella, MF | 1 |
| Batres, LA | 1 |
| Heesters, MS | 1 |
| Dice, JE | 1 |
| Featherstone, EA | 1 |
| Kripke, C | 1 |
| Vandenplas, Y | 3 |
| Richter, JE | 5 |
| Salvatore, S | 1 |
| Hauser, B | 1 |
| Wilson, DV | 1 |
| Evans, AT | 1 |
| Mauer, WA | 1 |
| Hibbs, AM | 1 |
| Lorch, SA | 1 |
| Kabakuş, N | 1 |
| Kurt, A | 1 |
| Khoshoo, V | 1 |
| Haydel, R | 1 |
| Keady, S | 1 |
| Gantz, M | 1 |
| Martin, RJ | 1 |
| Goldstein, RF | 1 |
| Goldberg, RN | 1 |
| Holloway, RH | 1 |
| Winnan, G | 1 |
| McCallum, RW | 12 |
| Castell, DO | 5 |
| Fink, SM | 3 |
| Lerner, E | 1 |
| Berkowitz, DM | 1 |
| Shapiro, GG | 1 |
| Christie, DL | 1 |
| Robinson, MG | 1 |
| Albibi, R | 1 |
| Wu, WC | 1 |
| Lange, RC | 2 |
| Winnan, GR | 1 |
| Avella, J | 1 |
| Callachan, C | 1 |
| Levin, G | 1 |
| Fisher, RS | 1 |
| Minami, H | 1 |
| Temple, JG | 1 |
| Bradby, GV | 1 |
| O'Connor, FO | 1 |
| Panesar, KS | 1 |
| Mulligan, TO | 1 |
| Robinson, TJ | 1 |
| Ward, DW | 1 |
| Shearer, RM | 1 |
| Bownes, IT | 1 |
| Curran, P | 1 |
| Taylor, DM | 1 |
| Winnicki, S | 1 |
| Florczak-Mikicińska, E | 1 |
| Pruszyńska-Podemska, W | 1 |
| Burrows, CF | 1 |
| Grill, BB | 1 |
| Leisner, B | 1 |
| Brückner, WL | 1 |
| Luderschmidt, C | 1 |
| Fuchs, B | 1 |
| Bartolomeo, RS | 1 |
| Quinn, SF | 1 |
| Caro Pérez, F | 1 |
| Sancho Fornos, S | 1 |
| García Fresquet, JV | 1 |
| Valero Rustarazo, J | 1 |
| Bright-Asare, P | 1 |
| El-Bassoussi, M | 1 |
| Pflücke, F | 3 |
| Schulze-Delrieu, K | 1 |
| Ponte, CD | 1 |
| Fahrländer, H | 1 |
| Bron, B | 1 |
| Lux, G | 2 |
| Engel, H | 1 |
| Rösch, W | 3 |
| Lane, JL | 1 |
| Hennig, FF | 1 |
| Siewert, R | 1 |
| Blum, AL | 2 |
| Bonardi, O | 1 |
| Güller, R | 2 |
| Seikaly, H | 1 |
| Park, P | 1 |
| Rival, R | 1 |
| Wong, R | 1 |
| Mendelsohn, M | 1 |
| Rosgen, S | 1 |
| Goldberg, M | 1 |
| Freeman, J | 1 |
| Jia, B | 1 |
| Robinson, M | 2 |
| Fanning, S | 1 |
| Ishisaka, DY | 1 |
| Merritt, TA | 1 |
| Whitley, NT | 1 |
| Robinson, D | 1 |
| Omar, SJ | 1 |
| Dangel, C | 1 |
| Fenn, H | 1 |
| Tinklenberg, J | 1 |
| Ramirez, B | 1 |
| Bauer, ML | 1 |
| Figueroa-Colon, R | 1 |
| Georgeson, K | 1 |
| Young, DW | 1 |
| Quigley, EM | 1 |
| Durazo, FA | 1 |
| Valenzuela, JE | 1 |
| Carella, G | 1 |
| Marra, L | 1 |
| Cannon, RA | 1 |
| Stadalnik, RC | 1 |
| Decktor, DL | 1 |
| Maton, PN | 1 |
| Sabesin, S | 1 |
| Roufail, W | 1 |
| Kogut, D | 1 |
| Roberts, W | 1 |
| McCullough, A | 1 |
| Pardoll, P | 1 |
| Saco, L | 1 |
| Grossi, L | 1 |
| Di Felice, F | 1 |
| Marzio, L | 1 |
| Pons, G | 3 |
| Duhamel, JF | 2 |
| Guillot, M | 2 |
| Gouyon, JB | 1 |
| d'Athis, P | 1 |
| Richard, MO | 1 |
| Rey, E | 1 |
| Moran, C | 1 |
| Bouglé, D | 1 |
| Bellissant, E | 2 |
| Noerr, B | 1 |
| Conley, SF | 1 |
| Werlin, SL | 1 |
| Beste, DJ | 1 |
| Talley, NJ | 1 |
| Heatley, DG | 1 |
| Swift, E | 1 |
| Belli, D | 1 |
| Benhamou, PH | 1 |
| Cadranel, S | 1 |
| Cezard, JP | 1 |
| Cucchiara, S | 1 |
| Dupont, C | 1 |
| Faure, C | 1 |
| Hassall, E | 1 |
| Heymans, HS | 1 |
| Kneepkens, CM | 1 |
| Sandhu, BK | 1 |
| Chinchilli, VM | 1 |
| Esinhart, JD | 1 |
| Reynolds, JC | 3 |
| Horn, JR | 1 |
| May, B | 1 |
| Greving, I | 1 |
| Flad, J | 1 |
| Christensen, RC | 1 |
| Byerly, MJ | 1 |
| Stille, CJ | 1 |
| Madani, S | 1 |
| Tolia, V | 2 |
| Pariente-Khayat, A | 1 |
| Olive, G | 1 |
| Hatlebakk, JG | 1 |
| Berstad, A | 1 |
| Champion, MC | 1 |
| Batts, KF | 1 |
| Munter, DW | 1 |
| Nowicki, MJ | 1 |
| Peterson, RB | 1 |
| Kearns, GL | 2 |
| van den Anker, JN | 1 |
| Reed, MD | 1 |
| Blumer, JL | 1 |
| Sridhar, KR | 1 |
| Magyar, L | 1 |
| Soykan, I | 1 |
| Coffin, B | 1 |
| Mukhopadhyay, K | 1 |
| Narang, A | 1 |
| Kumar, P | 1 |
| Chakraborty, S | 1 |
| Mittal, BR | 1 |
| Orenstein, SR | 3 |
| Sarría Echegaray, P | 1 |
| Tomás Barberán, M | 1 |
| Mas Mercant, S | 1 |
| Soler Vilarrasa, R | 1 |
| Romaguera Lliso, A | 1 |
| Kimball, AL | 1 |
| Carlton, DP | 1 |
| Storr, M | 1 |
| Meining, A | 1 |
| Allescher, HD | 1 |
| Maceri, DR | 1 |
| Zim, S | 1 |
| Arendt, R | 1 |
| Hollander, D | 1 |
| Karris, G | 1 |
| Johnson, AG | 2 |
| Ippoliti, AF | 1 |
| Cooney, C | 1 |
| Sturdevant, RA | 2 |
| De Loore, I | 1 |
| Van Ravensteyn, H | 1 |
| Ameryckx, L | 1 |
| Wright, DJ | 1 |
| Pandya, A | 1 |
| Laitinen, S | 1 |
| Mokka, RE | 1 |
| Valanne, JV | 1 |
| Larmi, TK | 1 |
| Brock-Utne, JG | 1 |
| Dow, TG | 1 |
| Welman, S | 1 |
| Dimopoulos, GE | 1 |
| Moshal, MG | 1 |
| Bucher, P | 1 |
| Lepsien, G | 1 |
| Weber, K | 1 |
| Giger, M | 1 |
| Sonnenberg, A | 1 |
| Cohen, S | 3 |
| Snape, WJ | 1 |
| Greaney, MG | 1 |
| Irvin, TT | 1 |
| Chattopadhyay, DK | 1 |
| Hey, VM | 1 |
| Behar, J | 1 |
| Biancani, P | 1 |
| Ottenjann, R | 1 |
| Thommesen, P | 1 |
| Salter, RH | 2 |
| Kline, MM | 1 |
| Curry, N | 1 |
| Jian, R | 1 |
| Wolfe, MM | 1 |
| Putnam, PE | 2 |
| Wessel, HB | 1 |
| Stowe, RM | 1 |
| Taurand, P | 1 |
| Spechler, SJ | 1 |
| Mohandas, KM | 1 |
| Santhi Swaroop, V | 1 |
| Krishnamurthy, S | 1 |
| Desai, DC | 1 |
| Dhir, V | 1 |
| Nagral, A | 1 |
| Marino, WD | 1 |
| Pitchumoni, CS | 1 |
| Orr, WC | 1 |
| Finn, A | 1 |
| Wilson, T | 1 |
| Russell, J | 1 |
| Dewailly, J | 1 |
| DiPalma, JR | 1 |
| Russell, JE | 1 |
| Gedye, A | 1 |
| Calhoun, J | 1 |
| Kuhns, L | 1 |
| Kauffman, RE | 1 |
| Wienbeck, M | 1 |
| Li, Q | 1 |
| Nimmo, WS | 1 |
| Pelemans, W | 1 |
| Vantrappen, G | 1 |
| Hillemeier, C | 1 |
| McCallum, R | 1 |
| Oertel, R | 1 |
| Gryboski, J | 1 |
| Tytgat, GN | 2 |
| Nio, CY | 1 |
| Arabehety, JT | 1 |
| Leitão, OR | 1 |
| Fassler, S | 1 |
| Olarte, M | 1 |
| Serrano, C | 1 |
| Hamilton, FA | 1 |
| Ricci, DA | 1 |
| Lieberman, DA | 1 |
| Machida, HM | 1 |
| Forbes, DA | 1 |
| Gall, DG | 1 |
| Scott, RB | 1 |
| Miller, CD | 1 |
| Anderson, WG | 1 |
| Fiser, DH | 1 |
| Desmond, PV | 1 |
| Watson, KJ | 1 |
| Kinni, ME | 1 |
| Stout, MM | 1 |
| DeVault, KR | 1 |
| Velek, M | 1 |
| Stanford, GK | 1 |
| Marco, L | 1 |
| Rode, H | 1 |
| Stunden, RJ | 1 |
| Millar, AJ | 1 |
| Cywes, S | 1 |
| Ramenofsky, ML | 1 |
| Powell, RW | 1 |
| Curreri, PW | 1 |
| Maddern, GJ | 1 |
| Kiroff, GK | 1 |
| Leppard, PI | 1 |
| Jamieson, GG | 1 |
| Shih, WJ | 1 |
| DeLand, FH | 1 |
| Uribe, M | 1 |
| Ballesteros, A | 1 |
| Strauss, R | 1 |
| Rosales, J | 1 |
| Garza, J | 1 |
| Villalobos, A | 1 |
| Briones, A | 1 |
| Garcia Ramos, G | 1 |
| Albot, G | 1 |
| Coignet, J | 1 |
| Berardi, RR | 1 |
| Cornish, LA | 1 |
| Hyneck, ML | 1 |
| Pfliuke, F | 1 |
| Linar, EIu | 1 |
| Bingham, JA | 1 |
| Paull, A | 1 |
| Kerr, A | 1 |
| Grant, AK | 1 |
| Venables, CW | 1 |
| Bell, D | 1 |
| Eccleston, D | 1 |
| Bennett, JR | 1 |
| Stanciu, C | 1 |
| Robinson, OP | 1 |
| Guelrud, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Metoclopramide for the Prevention of Gastroesophageal Reflux in Premature Infants Followed in an Outpatient Kangaroo Mother Care Clinic Before 40 Weeks of Gestational Age: A Randomized Controlled Trial[NCT02907632] | Phase 4 | 490 participants (Actual) | Interventional | 2017-04-26 | Completed | ||
| Cross-over Trial of Medical Treatment for GERD in Preterm Infants[NCT00131248] | Phase 3 | 18 participants (Actual) | Interventional | 2004-04-30 | Completed | ||
| Comparison of the Efficacy of Alginate-based Reflux Suppressant and Magnesium-aluminium Antacid Gel for Treatment of Heartburn in Pregnancy : A Randomized Double-Blind Controlled Trial[NCT02470117] | Phase 4 | 100 participants (Actual) | Interventional | 2015-06-30 | Completed | ||
| Effects of Non-nutritive Sucking on Gastroesophageal Reflux, Apneas and Bradycardias in Symptomatic Preterm Infants.[NCT02023216] | 30 participants (Actual) | Observational | 2013-05-31 | Completed | |||
| Generic Database: A Survey of Morbidity and Mortality in Very Low Birth Weight Infants[NCT00063063] | 80,000 participants (Anticipated) | Observational | 1987-01-31 | Recruiting | |||
| Effect of Different Modalities of Enteral Tube Feeding (ETF) on Gastroesophageal Reflux (GER) in Symptomatic Preterm Infants[NCT02837627] | 31 participants (Actual) | Observational | 2016-01-01 | Completed | |||
| Follow-up Visit of High Risk Infants[NCT00009633] | 68,000 participants (Anticipated) | Observational | 1993-01-31 | Recruiting | |||
| The Effect of Metoclopramide on Feeding in Very Low Birthweight Newborns : a Randomized, Double Blind, Placebo Controlled Pilot Study and a Proposal for a Multicentre Trial[NCT00242450] | Phase 4 | 30 participants | Interventional | 2002-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00131248)
Timeframe: 7 days
| Intervention | episodes per day (Mean) |
|---|---|
| Medications | 4.6 |
| Placebo | 3.6 |
55 reviews available for metoclopramide and Esophageal Reflux
| Article | Year |
|---|---|
Beers list: what's NOT on "tap" for the older adult.
Topics: Aged, 80 and over; Antiemetics; Antihypertensive Agents; Arthritis; Chlorpropamide; Confusion; Diabe | 2013 |
High dose of prokinetics for refractory hiccups after chemotherapy or the return to a simple drug.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Domperidone; Dopamine Antagonists | 2013 |
[Current issues on gastroesophageal reflux disease].
Topics: Alginates; Endoscopy, Gastrointestinal; Esophageal pH Monitoring; GABA-B Receptor Agonists; Gastroes | 2014 |
The outpatient management and special considerations of nausea and vomiting in pregnancy.
Topics: Ambulatory Care; Antiemetics; Diet Therapy; Doxylamine; Female; Fluid Therapy; Gastroesophageal Refl | 2014 |
GORD in children.
Topics: Acute Disease; Administration, Oral; Child; Cross-Sectional Studies; Domperidone; Gastroesophageal R | 2008 |
WITHDRAWN: Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years.
Topics: Dopamine Antagonists; Gastroesophageal Reflux; Humans; Infant; Infant Food; Metoclopramide; Posture; | 2010 |
[Prokinetics in childhood].
Topics: Adolescent; Anti-Ulcer Agents; Antiemetics; Bethanechol; Child; Child, Preschool; Cisapride; Cross-S | 2010 |
Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates.
Topics: Dopamine Antagonists; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infant, Newborn; In | 2012 |
Treatment of gastroesophageal reflux disease.
Topics: Antacids; Esophagoscopy; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Metoclopramide; | 2003 |
Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years.
Topics: Dopamine Antagonists; Gastroesophageal Reflux; Humans; Infant; Infant Food; Metoclopramide; Posture; | 2004 |
Prokinetic drug therapy in children: a review of current options.
Topics: Child; Controlled Clinical Trials as Topic; Erythromycin; Gastroesophageal Reflux; Humans; Metoclopr | 2005 |
Severe GERD: effective treatment prevents potentially serious complications.
Topics: Diagnosis, Differential; Digestive System Surgical Procedures; Education, Medical, Continuing; Gastr | 2005 |
Review article: the management of heartburn in pregnancy.
Topics: Antacids; Anti-Ulcer Agents; Cisapride; Female; Gastroesophageal Reflux; Gastrointestinal Motility; | 2005 |
The diagnosis and management of gastro-oesophageal reflux in infants.
Topics: Antacids; Cisapride; Domperidone; Erythromycin; Gastric Mucosa; Gastroesophageal Reflux; Histamine H | 2005 |
Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review.
Topics: Double-Blind Method; Dystonia; Gastroesophageal Reflux; Humans; Infant; Irritable Mood; Metocloprami | 2006 |
Update on drugs for gastro-oesophageal reflux disease.
Topics: Adolescent; Antacids; Child; Child, Preschool; Cisapride; Contraindications; Domperidone; Erythromyc | 2007 |
Upper gastrointestinal motility. Part I--The pathophysiologic approach to the management of reflux esophagitis.
Topics: Antacids; Bethanechol Compounds; Carbenoxolone; Esophagitis, Peptic; Esophagogastric Junction; Gastr | 1981 |
Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy.
Topics: Alginates; Antacids; Barium Sulfate; Bethanechol; Bethanechol Compounds; Cimetidine; Esophagitis, Pe | 1982 |
Gastroesophageal reflux and asthma.
Topics: Adolescent; Adult; Aged; Asthma; Bethanechol; Bethanechol Compounds; Child; Child, Preschool; Cimeti | 1983 |
Metoclopramide: pharmacology and clinical application.
Topics: Anorexia Nervosa; Antiemetics; Diabetes Mellitus; Dopamine Antagonists; Endocrine Glands; Gastric Em | 1983 |
Gastroesophageal reflux.
Topics: Antacids; Cimetidine; Esophagogastric Junction; Gastroesophageal Reflux; Heartburn; Humans; Metoclop | 1983 |
Gastroesophageal reflux disease: an update.
Topics: Antacids; Anti-Ulcer Agents; Bethanechol Compounds; Domperidone; Female; Gastroesophageal Reflux; Hu | 1983 |
The physiology and pathophysiology of gastric emptying in humans.
Topics: Achlorhydria; Anemia, Pernicious; Anorexia Nervosa; Gastric Emptying; Gastritis, Atrophic; Gastroeso | 1984 |
Drug therapy. Metoclopramide.
Topics: Dopamine Antagonists; Esophagitis; Gastric Emptying; Gastroesophageal Reflux; Gastrointestinal Motil | 1981 |
Prokinetic therapy for gastroesophageal reflux disease.
Topics: Bethanechol; Cisapride; Domperidone; Erythromycin; Gastroesophageal Reflux; Humans; Metoclopramide; | 1995 |
Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease.
Topics: Adult; Benzamides; Bethanechol; Bethanechol Compounds; Child; Cisapride; Erythromycin; Gastroesophag | 1993 |
Chronic pulmonary aspiration in children.
Topics: Bethanechol; Bethanechol Compounds; Bronchoscopy; Child; Chronic Disease; Diet Therapy; Gastric Acid | 1993 |
Modern management of dyspepsia.
Topics: Adult; Aged; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Child; C | 1996 |
Current concepts and issues in the management of regurgitation of infants: a reappraisal. Management guidelines from a working party.
Topics: Anti-Ulcer Agents; Antiemetics; Cisapride; Gastroesophageal Reflux; Humans; Infant; Infant Food; Met | 1996 |
Influence of pathophysiology, severity, and cost on the medical management of gastroesophageal reflux disease.
Topics: Aged; Anti-Ulcer Agents; Cisapride; Drug Interactions; Drug Therapy, Combination; Esophagitis, Pepti | 1996 |
Use of prokinetic agents in special populations.
Topics: Age Factors; Cisapride; Drug Interactions; Gastroesophageal Reflux; Gastrointestinal Agents; Gastroi | 1996 |
[Pharmacologic and clinical differentiation of prokinetic drugs].
Topics: Adult; Antiemetics; Child; Cisapride; Clinical Trials as Topic; Domperidone; Dopamine Antagonists; D | 1996 |
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidon | 1996 |
Prokinetic therapy in gastroesophageal reflux disease.
Topics: Cisapride; Domperidone; Esophagus; Gastroesophageal Reflux; Gastrointestinal Agents; Histamine H2 An | 1997 |
Dubowitz syndrome and achalasia: two rare conditions in a child.
Topics: Adolescent; Anti-Ulcer Agents; Antiemetics; Gastroesophageal Reflux; Humans; Infant, Low Birth Weigh | 1998 |
[Medical treatment of gastroesophageal reflux by prokinetic drugs].
Topics: Anti-Ulcer Agents; Benzamides; Cisapride; Dopamine Antagonists; Gastroesophageal Reflux; Humans; Met | 1999 |
[Gastroesophageal reflux in adults: diagnosis and treatment. Conclusions of Consensus Conference: long text. Organized by the French National Society of Gastroenterology and Belgian Royal Society of Gastroenterology/Flemish Society of Gastroenterology. Fr
Topics: Adult; Age Factors; Antacids; Anti-Ulcer Agents; Cisapride; Clinical Trials as Topic; Diagnosis, Dif | 1999 |
Management of supraesophageal complications of gastroesophageal reflux disease in infants and children.
Topics: Bethanechol; Child; Child, Preschool; Cimetidine; Cisapride; Fundoplication; Gastroesophageal Reflux | 2000 |
Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease.
Topics: Antacids; Anti-Ulcer Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Dopamine Antagonists; | 2001 |
The diagnosis and management of gastroesophageal reflux.
Topics: Bethanechol Compounds; Clinical Trials as Topic; Esophagogastric Junction; Female; Gastroesophageal | 1976 |
Gastroesophageal reflux: diagnosis and management.
Topics: Alginates; Antacids; Barium; Bethanechol Compounds; Cisapride; Endoscopy, Gastrointestinal; Gastric | 1992 |
Controversies in pediatric gastroesophageal reflux.
Topics: Bethanechol; Bethanechol Compounds; Child; Child, Preschool; Diagnosis, Differential; Esophagus; Gas | 1992 |
[Disorders of gastric emptying].
Topics: Cisapride; Diabetes Complications; Domperidone; Dyspepsia; Gastric Emptying; Gastroesophageal Reflux | 1992 |
Prokinetic agents.
Topics: Benzamides; Dopamine Antagonists; Gastric Emptying; Gastroesophageal Reflux; Gastrointestinal Agents | 1992 |
Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents.
Topics: Bethanechol; Bethanechol Compounds; Cisapride; Domperidone; Esophagogastric Junction; Gastric Emptyi | 1990 |
Cisapride--more selective than metoclopramide.
Topics: Cisapride; Dyspepsia; Gastroesophageal Reflux; Gastrointestinal Motility; Humans; Metoclopramide; Pi | 1990 |
Metoclopramide: a dopamine receptor antagonist.
Topics: Dopamine Antagonists; Drug Interactions; Gastroesophageal Reflux; Gastrointestinal Motility; Humans; | 1990 |
Prokinetic agents: a key in the future of gastroenterology.
Topics: Biomechanical Phenomena; Cisapride; Domperidone; Forecasting; Gastroenterology; Gastroesophageal Ref | 1989 |
Oesophageal disease in the elderly.
Topics: Age Factors; Aged; Alginates; Aluminum Hydroxide; Bethanechol Compounds; Bicarbonates; Deglutition D | 1985 |
The medical therapy of reflux oesophagitis.
Topics: Antacids; Bethanechol; Bethanechol Compounds; Cimetidine; Cisapride; Domperidone; Esophagitis, Pepti | 1987 |
Diagnosis and treatment of delayed gastric emptying.
Topics: Anemia, Pernicious; Anorexia Nervosa; Cisapride; Connective Tissue Diseases; Diabetes Complications; | 1988 |
Metoclopramide--a review.
Topics: Anxiety; Digestive System; Dopamine Antagonists; Drug Interactions; Female; Gastric Emptying; Gastro | 1986 |
Aspiration pneumonitis: predisposing conditions and prevention.
Topics: Atropine; Cimetidine; Citrates; Citric Acid; Duodenal Ulcer; Esophagogastric Junction; Gastric Acid; | 1986 |
[Primperan and gastroesophageal reflux. Review of the literature].
Topics: Bethanechol Compounds; Esophagogastric Junction; Esophagus; Gastric Emptying; Gastroesophageal Reflu | 1985 |
[Indications for primperan in pediatrics].
Topics: Anesthesia; Child, Preschool; Digestive System; Gastric Emptying; Gastroesophageal Reflux; Gastroint | 1985 |
44 trials available for metoclopramide and Esophageal Reflux
| Article | Year |
|---|---|
Randomized Clinical Trial of Metoclopramide as Prophylaxis of Gastroesophageal Reflux Disease in Preterm Infants.
Topics: Child; Gastroesophageal Reflux; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Prematur | 2021 |
Evaluation of the effectiveness of preoperative administration of maropitant citrate and metoclopramide hydrochloride in preventing postoperative clinical gastroesophageal reflux in dogs.
Topics: Animals; Dog Diseases; Dogs; Dopamine D2 Receptor Antagonists; Female; Gastroesophageal Reflux; Male | 2019 |
Pharmacokinetic comparison of orally-disintegrating metoclopramide with conventional metoclopramide tablet formulation in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Cross-Over Studies; Deglutition Disorders; Female; Gastroes | 2009 |
Cross-over trial of treatment for bradycardia attributed to gastroesophageal reflux in preterm infants.
Topics: Anti-Ulcer Agents; Bradycardia; Cross-Over Studies; Female; Gastroesophageal Reflux; Humans; Infant, | 2009 |
Effect of antireflux treatment on asthma exacerbations in nonatopic children.
Topics: Adolescent; Anti-Ulcer Agents; Antiemetics; Asthma; Child; Comorbidity; Enzyme Inhibitors; Esomepraz | 2007 |
Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients.
Topics: Bethanechol; Bethanechol Compounds; Gastric Emptying; Gastroesophageal Reflux; Humans; Metoclopramid | 1983 |
Effect of metoclopramide on normal and delayed gastric emptying in gastroesophageal reflux patients.
Topics: Analysis of Variance; Gastric Emptying; Gastroesophageal Reflux; Humans; Metoclopramide; Pentetic Ac | 1983 |
Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial.
Topics: Adult; Aged; Antacids; Clinical Trials as Topic; Double-Blind Method; Gastric Emptying; Gastroesopha | 1984 |
Cimetidine and metoclopramide in oesophageal reflux disease.
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Gastro | 1983 |
Prevention of meal-induced heartburn and regurgitation with metoclopramide in patients with gastroesophageal reflux.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Food; Gastroesophageal Reflux; Heartbu | 1982 |
Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux.
Topics: Adult; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Gastroesophageal Reflux; G | 1980 |
[Effect of metoclopramide on complaints of reflux disease].
Topics: Clinical Trials as Topic; Drug Evaluation; Gastroesophageal Reflux; Humans; Metoclopramide; Pentagas | 1981 |
[Effect of metoclopramide (Cerucal) on postprandial gastroesophageal reflux].
Topics: Clinical Trials as Topic; Electrodes; Esophagitis; Female; Gastroesophageal Reflux; Humans; Hydrogen | 1981 |
[Stimulation of esophageal motility with bromoprid, domperidon and metoclopramide. Therapy of esophageal reflux disease].
Topics: Adult; Benzimidazoles; Domperidone; Esophagogastric Junction; Female; Gastroesophageal Reflux; Human | 1980 |
Gastroesophageal reflux prophylaxis decreases the incidence of pharyngocutaneous fistula after total laryngectomy.
Topics: Adult; Aged; Anti-Ulcer Agents; Antiemetics; Cutaneous Fistula; Fistula; Gastroesophageal Reflux; Hu | 1995 |
Effect of single and repeated doses of metoclopramide on the mechanisms of gastroesophageal reflux.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Administration Schedule; Esophagogastric Junc | 1993 |
Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis.
Topics: Adult; Antacids; Circadian Rhythm; Drug Therapy, Combination; Esophagitis, Peptic; Female; Gastroeso | 1993 |
[A new granular effervescent 10-mg formulation of cisapride in the treatment of gastroesophageal reflux].
Topics: Adult; Aged; Cisapride; Double-Blind Method; Drug Combinations; Drug Tolerance; Female; Gastroesopha | 1993 |
Dose-response study of metoclopramide in gastroesophageal reflux in infancy.
Topics: Analysis of Variance; Dose-Response Relationship, Drug; Double-Blind Method; Esophagus; Female; Gast | 1993 |
Design and analysis of intra-subject variability in cross-over experiments.
Topics: Area Under Curve; Bronchodilator Agents; Clinical Trials as Topic; Cross-Over Studies; Ethanolamines | 1996 |
The triangular test to assess the efficacy of metoclopramide in gastroesophageal reflux.
Topics: Antiemetics; Double-Blind Method; Drug Administration Schedule; Esophagus; Female; Gastroesophageal | 1997 |
Prevalence of impaired gastric emptying of solids in systemic sclerosis: diagnostic and therapeutic implications.
Topics: Adult; Aged; Antiemetics; Esophagus; Female; Gastric Emptying; Gastroesophageal Reflux; Humans; Inje | 1998 |
A controlled trial of metoclopramide in symptomatic gastroesophageal reflux.
Topics: Antacids; Anxiety; Chronic Disease; Clinical Trials as Topic; Esophagus; Female; Gastroesophageal Re | 1977 |
Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide.
Topics: Antiemetics; Benzimidazoles; Child; Child, Preschool; Chronic Disease; Clinical Trials as Topic; Dou | 1979 |
Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Dietary Proteins; Eating; Esophagitis, Peptic | 1976 |
The diagnosis and management of gastroesophageal reflux.
Topics: Bethanechol Compounds; Clinical Trials as Topic; Esophagogastric Junction; Female; Gastroesophageal | 1976 |
Comparative effects of metoclopramide and bethanechol on lower esophageal sphincter pressure in reflux patients.
Topics: Administration, Oral; Adult; Aged; Bethanechol Compounds; Clinical Trials as Topic; Esophagogastric | 1975 |
What is intensive therapy for gastroesophageal reflux?
Topics: Antacids; Female; Follow-Up Studies; Gastroesophageal Reflux; Humans; Male; Metoclopramide; Ranitidi | 1992 |
Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group.
Topics: Antacids; Combined Modality Therapy; Esophagitis, Peptic; Female; Follow-Up Studies; Gastric Fundus; | 1992 |
Esophageal acid contact time and heartburn in acute treatment with ranitidine and metoclopramide.
Topics: Adult; Esophagus; Female; Gastroesophageal Reflux; Heartburn; Humans; Hydrogen-Ion Concentration; Ma | 1990 |
Metoclopramide for gastroesophageal reflux in infants.
Topics: Analysis of Variance; Double-Blind Method; Gastroesophageal Reflux; Humans; Infant; Metoclopramide | 1990 |
Randomized, prospective double-blind trial of metoclopramide and placebo for gastroesophageal reflux in infants.
Topics: Body Weight; Clinical Trials as Topic; Double-Blind Method; Gastric Emptying; Gastroesophageal Reflu | 1989 |
Cisapride in gastro-oesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH.
Topics: Administration, Oral; Cisapride; Clinical Trials as Topic; Esophagogastric Junction; Gastric Acidity | 1989 |
Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease.
Topics: Adult; Aged; Cisapride; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastroesophag | 1988 |
24-hour esophageal pH monitoring before and after medical therapy for reflux esophagitis.
Topics: Cimetidine; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration | 1988 |
Metoclopramide in gastroesophageal reflux of infancy.
Topics: Double-Blind Method; Esophagitis; Esophagogastric Junction; Esophagus; Female; Gastroesophageal Refl | 1988 |
Effects of antireflux therapies on salivary function in normal humans.
Topics: Adult; Bethanechol Compounds; Cimetidine; Gastroesophageal Reflux; Humans; Metoclopramide; Pirenzepi | 1987 |
Domperidone, metoclopramide, and placebo. All give symptomatic improvement in gastroesophageal reflux.
Topics: Adult; Aged; Domperidone; Double-Blind Method; Female; Gastric Emptying; Gastroesophageal Reflux; Hu | 1986 |
Successful administration of metoclopramide for the treatment of nausea in patients with advanced liver disease. A double-blind controlled trial.
Topics: Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Gastroesophageal Reflux; Hep | 1985 |
Metoclopramide (Reglan) for gastroesophageal reflux.
Topics: Adult; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Gastroesophageal Reflux; Humans; Metoclop | 1985 |
A controlled trail of metoclopramide in reflux oesophagitis.
Topics: Administration, Oral; Adult; Aged; Clinical Trials as Topic; Female; Gastroesophageal Reflux; Humans | 1974 |
Flatulent dyspepsia.
Topics: Clinical Trials as Topic; Dyspepsia; Female; Flatulence; Gastroesophageal Reflux; Heartburn; Humans; | 1973 |
A double-blind study of metoclopramide in symptomatic peptic oesophagitis.
Topics: Administration, Oral; Adult; Aged; Clinical Trials as Topic; Esophagitis; Female; Gastroesophageal R | 1973 |
The effect of metoclopramide on gastro-oesophageal reflux.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Esophagogastric Junction; Female; Gastroe | 1973 |
105 other studies available for metoclopramide and Esophageal Reflux
| Article | Year |
|---|---|
Prevalence, Risk Factors, and Management of Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy (a Retrospective Multicentric Study).
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Dexamethasone; Female; Gastrectomy; Gastroesophageal Re | 2023 |
Development of a Patient-Specific p.D85N-Potassium Voltage-Gated Channel Subfamily E Member 1-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for Drug-Induced Long QT Syndrome.
Topics: Adult; Amino Acid Substitution; Female; Gastroesophageal Reflux; Humans; Induced Pluripotent Stem Ce | 2021 |
Is metoclopramide safe for the premature infant?
Topics: Antiemetics; Dystonia; Gastroesophageal Reflux; Humans; Infant, Newborn; Infant, Premature; Infant, | 2013 |
Managing reflux in infants: lifestyle modifications or medications?
Topics: Antiemetics; Child Development; Disease Management; Esophagitis, Peptic; Gastroesophageal Reflux; Hi | 2014 |
Use and Safety of Erythromycin and Metoclopramide in Hospitalized Infants.
Topics: Enteral Nutrition; Erythromycin; Female; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; H | 2015 |
Prokinetics prescribing in paediatrics: evidence on cisapride, domperidone, and metoclopramide.
Topics: Adolescent; Antiemetics; Child; Child, Preschool; Cisapride; Domperidone; Drug Prescriptions; Gastro | 2015 |
Prevalence of Chronic Metoclopramide Use and Associated Diagnoses in the US Pediatric Population.
Topics: Child; Gastroesophageal Reflux; Humans; Metoclopramide; Pediatrics; Prevalence; United States | 2015 |
Metoclopramide does not attenuate cricoid pressure-induced relaxation of the lower esophageal sphincter in awake volunteers.
Topics: Adult; Cricoid Cartilage; Esophageal Sphincter, Lower; Esophageal Sphincter, Upper; Gastroesophageal | 2008 |
Galactorrhea with metoclopramide use in the neonatal unit.
Topics: Abnormalities, Multiple; Down Syndrome; Ductus Arteriosus, Patent; Follow-Up Studies; Galactorrhea; | 2009 |
Lansoprazole, ranitidine, and metoclopramide: comparison of practice patterns at 4 level III NICUs within one healthcare system.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Monitoring; Gastroesophageal Reflux | 2009 |
Patience is a virtue in the management of gastroesophageal reflux.
Topics: Bradycardia; Dopamine Antagonists; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infant | 2009 |
[Combined therapy of acid-dependent gastrointestinal disorders with the use of antacidic drug Relcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Antacids; Anti-Bacterial Agents; A | 2009 |
Esophageal hamartoma as an unusual cause of neonatal apnea and bradycardia.
Topics: Anti-Ulcer Agents; Apnea; Bradycardia; Esophageal Diseases; Female; Gastroesophageal Reflux; Hamarto | 2010 |
Evaluation of metoclopramide and ranitidine on the prevention of gastroesophageal reflux episodes in anesthetized dogs.
Topics: Anesthesia; Animals; Antiemetics; Dog Diseases; Dogs; Esophagoscopy; Female; Gastroesophageal Reflux | 2012 |
Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Chronic Disease; Cisapride; | 2003 |
Metoclopramide-induced tardive dyskinesia in an infant.
Topics: Adolescent; Child; Child, Preschool; Demography; Dopamine Antagonists; Dyskinesia, Drug-Induced; Fem | 2005 |
Index of suspicion.
Topics: Antiemetics; Child, Preschool; Diagnosis, Differential; Dystonia; Gastroesophageal Reflux; Humans; I | 2004 |
Treating GER in children younger than two years.
Topics: Antiemetics; Gastroesophageal Reflux; Humans; Infant; Infant Food; Metoclopramide; Posture | 2005 |
Gastroesophageal reflux: medical treatment.
Topics: Antacids; Child; Child, Preschool; Combined Modality Therapy; Esophageal Sphincter, Lower; Gastric F | 2005 |
Influence of metoclopramide on gastroesophageal reflux in anesthetized dogs.
Topics: Analysis of Variance; Animals; Antiemetics; Dogs; Dose-Response Relationship, Drug; Esophagus; Gastr | 2006 |
Sandifer Syndrome: a continuing problem of misdiagnosis.
Topics: Anemia, Iron-Deficiency; Bronchial Spasm; Diagnosis, Differential; Diagnostic Errors; Dopamine Antag | 2006 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationsh | 2008 |
Management of reflux esophageal disease.
Topics: Bethanechol Compounds; Esophagogastric Junction; Gastroesophageal Reflux; Histamine H2 Antagonists; | 1984 |
Tardive akathisia and agitated depression during metoclopramide therapy.
Topics: Akathisia, Drug-Induced; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Gastroesophageal Ref | 1984 |
Evaluation of the safety of metoclopramide in patients with gastroesophageal reflux disease.
Topics: Adult; Electrocardiography; Eye Diseases; Female; Gastroesophageal Reflux; Hearing Disorders; Humans | 1984 |
[Usefulness of metoclopramidum-Polfa in the roentgenological diagnosis of defects of the gastrointestinal system in children].
Topics: Adolescent; Barium Sulfate; Child; Child, Preschool; Gastroesophageal Reflux; Gastrointestinal Motil | 1984 |
Metoclopramide.
Topics: Animals; Atropine; Cat Diseases; Cats; Central Nervous System; Digestive System; Dog Diseases; Dogs; | 1983 |
Treatment of gastroesophageal reflux.
Topics: Bethanechol Compounds; Cimetidine; Domperidone; Gastroesophageal Reflux; Humans; Infant; Infant, New | 1984 |
[Modification of pathologic gastroesophageal reflux by bromopride. Results of function scintigraphy].
Topics: Gastroesophageal Reflux; Humans; Metoclopramide; Pentetic Acid; Radionuclide Imaging; Technetium; Te | 1982 |
Respiratory failure due to metoclopramide.
Topics: Adult; Diphenhydramine; Gastroesophageal Reflux; Humans; Intubation, Intratracheal; Male; Metoclopra | 1983 |
[Manometric evaluation of drug therapy in gastroesophageal reflux].
Topics: Adult; Esophagus; Female; Gastroesophageal Reflux; Humans; Male; Manometry; Metoclopramide; Middle A | 1983 |
Metoclopramide in the treatment of an infant with gastroesophageal hypomotility.
Topics: Gastroesophageal Reflux; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Infant, Newbo | 1982 |
[Pathophysiology, clinical aspects and therapy of gastro-esophageal reflux disease].
Topics: Antacids; Barrett Esophagus; Candidiasis; Cholic Acids; Cimetidine; Diagnosis, Differential; Endosco | 1981 |
[Physiopathology, diagnosis and treatment of esophageal reflux].
Topics: Alginates; Benzimidazoles; Diagnostic Errors; Diet, Reducing; Dietary Fats; Domperidone; Electrodes; | 1981 |
Lump in the throat.
Topics: Adult; Aluminum Hydroxide; Esophagus; Female; Gastroesophageal Reflux; Humans; Male; Metoclopramide; | 1980 |
[Duodenogastric reflux and therapy with bromoprid].
Topics: Adult; Aged; Bile; Cholagogues and Choleretics; Gastric Juice; Gastric Mucosa; Gastroesophageal Refl | 1980 |
[Drug therapy of gastrointestinal motility disorders].
Topics: Antacids; Atropine; Carbenoxolone; Colonic Diseases, Functional; Deglutition Disorders; Diarrhea; Du | 1980 |
[Therapy of esophageal reflux disease].
Topics: Aluminum Hydroxide; Esophagitis; Esophagitis, Peptic; Esophagoscopy; Gastroesophageal Reflux; Humans | 1980 |
[Gastro-esophageal reflux].
Topics: Antacids; Bethanechol Compounds; Cimetidine; Esophagogastric Junction; Gastroesophageal Reflux; Gast | 1980 |
[Therapy of gastro-esophageal reflux disease].
Topics: Alginates; Antacids; Cimetidine; Esophagogastric Junction; Esophagoscopy; Gastroesophageal Reflux; H | 1980 |
Role of gastroesophageal reflux disease in patients with cervical symptoms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barium Sulfate; Biopsy; Cineradiograp | 1995 |
[Drug therapy of gastrointestinal motility disorders].
Topics: Cisapride; Domperidone; Dyspepsia; Gastroesophageal Reflux; Gastroparesis; Humans; Metoclopramide; P | 1995 |
Possible metoclopramide-induced increase in serum aldosterone in a premature infant.
Topics: Aldosterone; Gastroesophageal Reflux; Humans; Hyperaldosteronism; Infant; Infant, Newborn; Infant, P | 1995 |
Megaoesophagus and glucocorticoid-deficient hypoadrenocorticism in a dog.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Animals; Cimetidine; Dexamethasone; Dog Diseases | 1995 |
Metoclopramide-induced extra pyramidal symptoms in a diabetic patient.
Topics: Aged; Akathisia, Drug-Induced; Diabetes Mellitus, Type 2; Dyskinesia, Drug-Induced; Gastroesophageal | 1994 |
Gastroesophageal reflux disease: the roles of motility in pathophysiology and therapy.
Topics: Esophagogastric Junction; Gastroesophageal Reflux; Humans; Metoclopramide | 1993 |
[Prokinetic drugs in digestive disorders].
Topics: Antineoplastic Agents; Cisapride; Domperidone; Esophageal Motility Disorders; Gastroesophageal Reflu | 1993 |
Postprandial gastric motility in infants with gastroesophageal reflux and delayed gastric emptying.
Topics: Bottle Feeding; Esophagus; Gastric Emptying; Gastroesophageal Reflux; Gastrointestinal Motility; Hum | 1993 |
Metoclopramide.
Topics: Gastric Emptying; Gastroesophageal Reflux; Gastrointestinal Motility; Humans; Infant; Infant, Newbor | 1993 |
Proximal pH-metry for diagnosis of upper airway complications of gastroesophageal reflux.
Topics: Airway Obstruction; Antiemetics; Bethanechol; Child, Preschool; Choanal Atresia; Cimetidine; Endosco | 1995 |
Paradoxical vocal cord dysfunction in an infant with stridor and gastroesophageal reflux.
Topics: Anti-Ulcer Agents; Antiemetics; Bronchoscopy; Drug Therapy, Combination; Female; Gastroesophageal Re | 1996 |
[Internal medicine therapy in reflux disease].
Topics: Antacids; Antiemetics; Clinical Protocols; Esophagitis, Peptic; Gastroesophageal Reflux; Gastrointes | 1996 |
Quality problems that result in adverse outcomes provide opportunities for quality improvement.
Topics: Adult; Anti-Ulcer Agents; Antiemetics; Continuity of Patient Care; Drug Therapy, Combination; Dyskin | 1996 |
Mandibular dystonia associated with the combination of sertraline and metoclopramide.
Topics: 1-Naphthylamine; Adult; Basal Ganglia Diseases; Depressive Disorder; Drug Interactions; Dystonia; Fe | 1996 |
Index of Suspicion. Case 1. Dystonic reaction to metoclopramide.
Topics: Antiemetics; Basal Ganglia Diseases; Dystonia Musculorum Deformans; Gastroesophageal Reflux; Humans; | 1997 |
Gynecomastia with metoclopramide use in pediatric patients.
Topics: Adolescent; Dopamine Antagonists; Galactorrhea; Gastroesophageal Reflux; Gynecomastia; Humans; Infan | 1997 |
Metoclopramide toxicity in an infant.
Topics: Antiemetics; Drug Overdose; Dystonia; Gastroesophageal Reflux; Humans; Infant; Infant Care; Male; Me | 1998 |
Pharmacokinetics of metoclopramide in neonates.
Topics: Administration, Oral; Age Factors; Antiemetics; Female; Gastroesophageal Reflux; Humans; Infant, New | 1998 |
Gastroesophageal reflux and pulmonary complication in a neonate.
Topics: Antiemetics; Apnea; Cisapride; Follow-Up Studies; Gastroesophageal Reflux; Gastrointestinal Agents; | 1998 |
[Pharmacological prophylaxis of gastroesophageal reflux. Incidence of pharyngocutaneous fistula after total laryngectomy].
Topics: Cutaneous Fistula; Dopamine Antagonists; Female; Gastroesophageal Reflux; Humans; Incidence; Larynge | 2000 |
Gastroesophageal reflux medications in the treatment of apnea in premature infants.
Topics: Apnea; Cisapride; Female; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Infant, Newborn; | 2001 |
Laryngospasm: an atypical manifestation of severe gastroesophageal reflux disease (GERD).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Enzyme Inhibito | 2001 |
The effect of metoclopramide on gastro-oesophageal reflux.
Topics: Drug Evaluation; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Metoclop | 1977 |
Medical measures that influence the gastroesophageal junction.
Topics: Alginates; Alkalies; Aluminum Hydroxide; Bethanechol Compounds; Bicarbonates; Drug Combinations; Eso | 1978 |
Efficacy of medical management of gastroesophageal reflux: a critical assessment.
Topics: Alginates; Aluminum Hydroxide; Antacids; Bethanechol Compounds; Bicarbonates; Drug Combinations; Eso | 1978 |
Cholecystectomy and gallstone dyspepsia. Clinical and physiological study of a symptom complex.
Topics: Adult; Bilirubin; Cholecystectomy; Cholelithiasis; Digestive System; Duodenal Diseases; Dyspepsia; F | 1975 |
[Functional disorders of the esophagus. Diagnosis and therapy].
Topics: Antacids; Collagen Diseases; Deglutition Disorders; Dietary Proteins; Esophageal Achalasia; Esophage | 1979 |
Smoking and gastric juice volume in outpatients.
Topics: Adult; Anesthesia, Dental; Anesthesia, General; Antacids; Gastric Acidity Determination; Gastric Jui | 1979 |
Anaesthesia induction and lower oesophageal sphincter pressure.
Topics: Anesthesia, General; Anesthetics; Animals; Atropine; Dogs; Drug Evaluation, Preclinical; Drug Intera | 1978 |
The effect of metoclopramide on the lower oesophageal sphincter in late pregnancy.
Topics: Adolescent; Adult; Esophagogastric Junction; Female; Gastroesophageal Reflux; Heartburn; Humans; Met | 1978 |
[Treatment of reflux disease (author's transl)].
Topics: Alginates; Antacids; Body Weight; Cimetidine; Esophagitis; Gastroesophageal Reflux; Humans; Metoclop | 1978 |
The pathophysiology and treatment of gastroesophageal reflux disease: new concepts.
Topics: Bethanechol Compounds; Cimetidine; Esophagogastric Junction; Esophagus; Gastrins; Gastroesophageal R | 1978 |
The measurement of resting and stimulated lower esophageal sphincter pressure using the rapid pull-through technique of esophageal manometry.
Topics: Adult; Aged; Bethanechol Compounds; Esophagogastric Junction; Evaluation Studies as Topic; Gastroeso | 1978 |
Gastro-oesophageal reflux in pregnancy: a review article.
Topics: Esophagogastric Junction; Female; Gastrins; Gastroesophageal Reflux; Hernia, Hiatal; Humans; Metoclo | 1978 |
Oesophageal reflux and its myths.
Topics: Esophagogastric Junction; Gastroesophageal Reflux; Humans; Metoclopramide | 1979 |
[Therapy of gastroesophageal reflux].
Topics: Antacids; Bethanechol Compounds; Gastroesophageal Reflux; Humans; Metoclopramide | 1977 |
Abnormal duodenal loop and pyloric regurgitation.
Topics: Adult; Duodenum; Dyspepsia; Female; Gastroesophageal Reflux; Humans; Male; Metoclopramide; Middle Ag | 1977 |
[Gastro-esophageal Reflux (present concept of pathogenesis and therapy (author's transl)].
Topics: Antacids; Body Weight; Gastroesophageal Reflux; Metoclopramide; Posture; Pressure | 1976 |
Common gastroenterological problems. II.--Sliding hiatus hernia.
Topics: Antacids; Diagnosis, Differential; Diet, Reducing; Dietary Fats; Gastroesophageal Reflux; Gastrointe | 1975 |
Recent advances in management of gastroesophageal reflux.
Topics: Antacids; Bethanechol Compounds; Biopsy; Diet Therapy; Esophagoscopy; Esophagus; Gastroesophageal Re | 1975 |
Tardive dyskinesia associated with use of metoclopramide in a child.
Topics: Child, Preschool; Chronic Disease; Combined Modality Therapy; Drug Therapy, Combination; Dyskinesia, | 1992 |
[A severe malaise in infants].
Topics: Domperidone; Gastroesophageal Reflux; Humans; Infant; Male; Metoclopramide; Posture | 1992 |
Sentinel polyp and fold: resolution following drug therapy.
Topics: Esophageal Neoplasms; Esophagogastric Junction; Female; Gastroesophageal Reflux; Humans; Male; Metoc | 1992 |
Reversal of negative pressure ventilation-induced lower esophageal sphincter dysfunction with metoclopramide.
Topics: Diaphragm; Esophagogastric Junction; Female; Gastroesophageal Reflux; Humans; Male; Metoclopramide; | 1992 |
Self-injury, regurgitation, and antiemetics.
Topics: Adult; Domperidone; Down Syndrome; Gastroesophageal Reflux; Humans; Intellectual Disability; Male; M | 1989 |
Aspiration of gastric contents.
Topics: Administration, Oral; Analgesics, Opioid; Anesthesia; Anesthesia, Obstetrical; Cimetidine; Citrates; | 1985 |
Effect of bethanechol and metoclopramide on upper gastrointestinal motility in the kitten.
Topics: Animals; Bethanechol; Bethanechol Compounds; Cats; Esophagogastric Junction; Esophagus; Gastric Empt | 1986 |
A critical review of current medical therapy for gastroesophageal reflux disease.
Topics: Alginates; Antacids; Barrett Esophagus; Bethanechol; Bethanechol Compounds; Cimetidine; Gastroesopha | 1986 |
[Therapeutic procedures in gastroesophageal reflux disease].
Topics: Alginates; Aluminum Hydroxide; Antacids; Bicarbonates; Combined Modality Therapy; Dilatation; Domper | 1986 |
Long-term therapy for chronic gastroesophageal reflux.
Topics: Chronic Disease; Cimetidine; Drug Therapy, Combination; Esophagogastric Junction; Gastroesophageal R | 1987 |
Metoclopramide-induced akathisia.
Topics: Adult; Akathisia, Drug-Induced; Gastroesophageal Reflux; Humans; Male; Metoclopramide | 1987 |
Silent regurgitation in day case gynaecological patients.
Topics: Adult; Ambulatory Surgical Procedures; Female; Gastroesophageal Reflux; Genital Diseases, Female; Hu | 1988 |
Metoclopramide-induced methemoglobinemia.
Topics: Gastroesophageal Reflux; Humans; Infant, Newborn; Male; Methemoglobinemia; Methylene Blue; Metoclopr | 1988 |
Priapism associated with concurrent use of thioridazine and metoclopramide.
Topics: Adult; Drug Synergism; Drug Therapy, Combination; Gastroesophageal Reflux; Humans; Male; Metoclopram | 1987 |
Esophageal pH assessment of gastroesophageal reflux in 18 patients and the effect of two prokinetic agents: cisapride and metoclopramide.
Topics: Cisapride; Esophagus; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Infant; Metoclopr | 1987 |
Gastroesophageal reflux. pH probe-directed therapy.
Topics: Apnea; Barium Sulfate; Esophagogastric Junction; Esophagus; Female; Gastroesophageal Reflux; Humans; | 1986 |
Scintigraphy in disorders of the gastrointestinal tract.
Topics: Child; Child, Preschool; Diagnosis, Differential; Female; Gastric Emptying; Gastroesophageal Reflux; | 1985 |
Metoclopramide removal during continuous ambulatory peritoneal dialysis.
Topics: Gastroesophageal Reflux; Humans; Kidney Failure, Chronic; Male; Metoclopramide; Middle Aged; Periton | 1986 |
[Effect of metoclopramide on pentagastrin-stimulated gastroesophageal reflux].
Topics: Esophagogastric Junction; Female; Gastroesophageal Reflux; Humans; Male; Metoclopramide; Pentagastri | 1985 |
Review of the current status of prokinetic agents in gastroenterology.
Topics: Benzamides; Chemical Phenomena; Chemistry; Cisapride; Dexamethasone; Digestive System; Domperidone; | 1985 |
Lower oesophageal sphincter: therapeutic implications.
Topics: Antacids; Deglutition; Drug Evaluation; Esophagogastric Junction; Esophagus; Gastroesophageal Reflux | 1974 |
Medical management of heartburn.
Topics: Alginates; Alkalies; Anesthetics, Local; Bethanechol Compounds; Diet; Esophagus; Gastric Acidity Det | 1974 |
Evolution and early results of constructing an anti-reflux valve in the stomach.
Topics: Barium Sulfate; Deglutition Disorders; Gastroesophageal Reflux; Hernia, Diaphragmatic; Humans; Metho | 1974 |
Metoclopramide--a new pharmacological approach?
Topics: Animals; Antiemetics; Gastroesophageal Reflux; Gastrointestinal Motility; Humans; Metoclopramide; Vo | 1973 |
Effect of intravenous metoclopramide on the incompetent lower esophageal sphincter.
Topics: Atropine; Esophagogastric Junction; Esophagus; Female; Gastroesophageal Reflux; Hernia, Diaphragmati | 1974 |